Is the folk medicine known as "The Secret" efficient in reducing bleeding after percutaneous coronary procedures?: a

Charlie Ferry1, Serban Puricel2, Sonja Lehmann2

  • 1Cardiology, University of Fribourg, Fribourg, Switzerland charlie.ferry@unifr.ch.

Open Heart
|December 20, 2022
PubMed

Insights

This study found that "The Secret," a pagan prayer, did not reduce bleeding complications after percutaneous coronary interventions. Patient belief in its efficacy did not correlate with actual outcomes in reducing bleeding events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Ethics

Background:

  • Percutaneous coronary interventions (PCI) carry a risk of bleeding complications due to arterial access and antithrombotic therapy.
  • Minimizing bleeding is crucial for patient safety and recovery after PCI procedures.

Purpose of the Study:

  • To evaluate the efficacy of "The Secret," a pagan prayer, in reducing post-interventional bleeding after PCI.
  • To assess patient perceptions regarding the potential benefits of spiritual interventions on medical outcomes.

Main Methods:

  • A randomized controlled trial was conducted at a single, tertiary care center.
  • 200 patients undergoing elective coronary angiography were randomized to receive "The Secret" in addition to standard care or standard care alone.
  • The primary outcome was in-hospital bleeding, categorized using the Bleeding Academic Research Consortium (BARC) criteria.

Main Results:

  • No significant difference in bleeding rates was observed between the intervention group (receiving "The Secret") and the control group across all BARC severity levels (BARC 1, 2, 3, and 5).
  • Specifically, BARC 1 bleeding occurred in 16% vs. 14% (p=0.69) and BARC 2 in 12% vs. 13% (p=0.81).
  • A substantial majority (76%) of participants expressed a belief in the prayer's ability to prevent bleeding, despite the lack of observed effect.

Conclusions:

  • "The Secret" demonstrated no measurable effect on reducing bleeding complications following percutaneous coronary procedures.
  • While patients often believe in the positive impact of spiritual practices on healthcare, this study found no clinical benefit for this specific intervention.
  • Further research may explore the psychological impact of belief in interventions, but clinical efficacy for bleeding prevention was not supported.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
19
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
585
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K